Insider trade

Serina Therapeutics (SER): Chief Scientific Officer sold ~$38K

Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, sold ~$38K of Serina Therapeutics shares.

~$38K
Approx. value · 6,500 sh @ $5.78
Traded
Jun 30, 2025
Filed
Jul 2, 2025

What stands out in this filing

  • The sale emptied this holding: the filing reports no shares left in it afterwards.
  • 6,500 shares at an average of $5.78 each, as reported on the form.
  • Filing box checked: sold under a Rule 10b5-1 plan.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 30, 2025 · this disclosureInsiderOfficer sold ~$38K of SER shares in the open market

What came next

  1. Jul 7, 2025InsiderOfficer sold ~$37K of SER shares in the open market
  2. Jul 14, 2025InsiderOfficer sold ~$33K of SER shares in the open market
  3. Jul 21, 2025InsiderOfficer sold ~$35K of SER shares in the open market
  4. Jul 29, 2025InsiderOfficer sold ~$27K of SER shares in the open market
  5. Aug 4, 2025InsiderOfficer sold ~$28K of SER shares in the open market
  6. Aug 12, 2025InsiderOfficer sold ~$29K of SER shares in the open market
  7. Aug 18, 2025InsiderOfficer sold ~$12K of SER shares in the open market
  8. Aug 20, 2025InsiderOfficer sold ~$11K of SER shares in the open market
  9. Aug 25, 2025InsiderOfficer sold ~$12K of SER shares in the open market
  10. Sep 9, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  11. Oct 13, 2025InsiderOfficer sold ~$22K of SER shares in the open market
  12. Oct 20, 2025InsiderOfficer sold ~$32K of SER shares in the open market
  13. Oct 27, 2025InsiderOfficer sold ~$4.9K of SER shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Serina Therapeutics

OQRO holds no insider, Congress, fund or contract record for Serina Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SER page.

Other recent filings by Randall Moreadith, Chief Scientific Officer

The full history of Randall Moreadith, Chief Scientific Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Serina Therapeutics (SER) insider traded, and how much?

Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, sold ~$38K of Serina Therapeutics shares. 6,500 shares at $5.78.

When did it happen, and when was it made public?

Traded: Jun 30, 2025. Filed: Jul 2, 2025. That is 2 days between the two dates.

What stands out in this filing?

The sale emptied this holding: the filing reports no shares left in it afterwards. 6,500 shares at an average of $5.78 each, as reported on the form. Filing box checked: sold under a Rule 10b5-1 plan.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean SER stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Serina Therapeutics

Everything OQRO holds on this company is on its SER page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data